AMT-126
/ Rafael Holdings
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
July 27, 2022
SAD Study to Assess the Safety, Tolerability, PK, and In-Vivo Performance of AMT-126 in Healthy Male and Female Subjects
(clinicaltrials.gov)
- P1 | N=50 | Completed | Sponsor: Applied Molecular Transport
New P1 trial • Preclinical
1 to 1
Of
1
Go to page
1